IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Hikari Power Ltd

Q4 2019 Holdings

Filed 2020-02-04 | 111 holdings | $35.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Wells Fargo & Co(WFC)COM949746101$88.2K1,639,8800.2%
Corcept Therapeutics Inc(CORT)COM218352102$203.0K16,7900.6%
Abbvie Inc(ABBV)COM00287Y109$216.0K2,4400.6%
Biogen Inc(BIIB)COM09062X103$252.0K8500.7%
Berkshire Hathaway Inc Class A(BRK/A)CL A084670108$258.1K7600.7%
Corvus Pharmaceuticals Inc(CRVS)COM221015100$435.0K80,0001.2%
Aldeyra Therapeutics Inc(ALDX)COM01438T106$465.0K80,0201.3%
Anavex Life Sciences Corp(AVXL)COM032797300$1.1M429,2003.1%
Cisco Systems Inc(CSCO)COM17275R102$5.0M103,90014.0%
Deutsche X-Trackers Harvest CSI 300 China A-Shares Fund(ASHR)ETF233051879$8.1M271,68022.7%
Boeing Co(BA)COM097023105$18.9M57,90053.1%
PreviousPage 3 of 3